Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
To compare the effects of typical and atypical antipsychotic drugs on sleep activity and subjective sleep quality.
Randomised, double-blind, placebo-controlled, four-period cross-over, clinical trial was used to evaluate the effects of active treatments on objective and subjective sleep variables.
Sleep laboratory evaluation.
Twenty healthy young volunteers, both sexes.
Single oral morning administrations of olanzapine 5 mg, risperidone 1 mg, haloperidol 3 mg and placebo.
Measurements and results
Five polysomnographic nights were evaluated: one control night and one after each intervention. Significant increase in total sleep time, sleep efficiency, slow wave sleep (SWS) and rapid eye movement (REM) sleep with decreases in wake time were observed after olanzapine. Decreases in wake time, REM sleep and stage shifts together with increases in stage 2 were obtained after risperidone. Haloperidol showed only a tendency to increase sleep efficiency and stage 2 and to decrease wake time. Olanzapine showed decreases in power density in frequencies higher than 10 Hz during all sleep stages and in frequencies lower than 5 Hz range in SWS; decreases in the dynamics of spindle frequency activity (SFA) in the second and fourth non-rapid eye movement (NREM) episodes were also obtained. Risperidone presented increases in the 3.6–10.8 Hz frequency range in NREM sleep stages and in stage 2. Haloperidol also showed increases in NREM sleep stages and in stage 2, but these were in frequencies higher than 10 Hz, with increases in the dynamics of SFA in the first NREM episode. Only a significant improvement in subjective sleep quality was observed after olanzapine.
Antipsychotics showed different sleep changes as their neurochemical profiles were distinct. These changes were observed even when the drug was administered 15 h before going to bed.
- Aeschbach D, Borbély AA (1993) All night dynamics of the human sleep EEG. J Sleep Res 2:70–81
- Åkerstedt T, Hume K, Minors D, Waterhouse J (1994a) The meaning of good sleep: a longitudinal study of polysomnography and subjective sleep quality. J Sleep Res 3:152–158 CrossRef
- Åkerstedt T, Hume K, Minors D, Waterhouse J (1994b) The subjective meaning of good sleep—an intraindividual approach using the Karolinska Sleep Diary. Percept Mot Skills 79:287–296
- Åkerstedt T, Hume K, Minors D, Waterhouse J (1997) Good sleep—its timing and physiological characteristics. J Sleep Res 6:221–229 CrossRef
- Barbanoj MJ, Grasa E, Morte A, Romero S, Clos S, Giménez S, Benito Ll, Yritia M, Pérez V, Anderer P (2004) Topographic EEG changes after single oral doses of atypical neuroleptics with different pharmacological profile in healthy young subjects (abstract). 13th meeting of the IPEG (International Pharmaco–EEG Society), Amberes, Belgium (8–12 September)
- Borbély AA, Mattmann P, Loepfe M, Strauch I, Lehmann D (1983) Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. Hum Neurobiol 4:189–194
- Bobérly AA, Trachsel L, Tobler I (1988) Effect of ritanserin on sleep stages and sleep EEG in the rat. Eur J Pharmacol 156:275–278 CrossRef
- Dijk DJ, Beersma DGM, Daan S, Van den Hoofdakker RH (1989) Effects of seganserin, a 5HT2 antagonist, and temazepam on human sleep stages and EEG power spectra. Eur J Pharmacol 171:207–218 CrossRef
- Dugovic C, Wauquier A, Janssen PAJ (1989) Differential effects of the new antipsychotic risperidone on sleep and wakefulness in the rat. Neuropharmacology 28:1431–1433 CrossRef
- Feinberg I, Floyd TC (1979) Systematic trends across the night in human sleep cycles. Psychophysiology 16:282–291 CrossRef
- Itil TM, Gannon P, Hsu W, Klingenberg H (1970) Digital computer analyzed sleep and resting EEG during haloperidol treatment. Am J Psychiatry 127:462–471
- Janssen P, Niemeggeers CJ, Awouters F, Schellekens KH, Megens AA, Meert TF (1988) Pharmacology of risperidone (R64766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. J Pharmacol Exp Ther 244:685–693
- Lee DY, Lee KU, Kwon JS, Jang IJ, Cho MJ, Shin SG, Woo JI (1999) Pharmacokinetic–pharmacodynamic modeling of risperidone effects on electroencephalography in healthy volunteers. Psychopharmacology 144:272–278 CrossRef
- Lindberg N, Virkkunen M, Tani P, Appelberg B, Virkkala J, Rimón R, Porkka-Heiskanen T (2002) Effect of a single-dose of olanzapine on sleep in healthy females and males. Int Clin Psychopharmacol 17:177–184 CrossRef
- Maixner S, Tandon R, Eiser A, Taylor S, DeQuardo JR, Shipley J (1998) Effects of antipsychotic treatment on polysomnographic measures in schizophrenia: a replication and extension. Am J Psychiatry 155:1600–1602
- Miyamoto S, Duncan GE, Goff DC, Lieberman JA (2002) Therapeutics of schizophrenia. In: Davis KL, Charney D, Coyle JT, Nemeroff C (eds) American College of Neuropsychopharmacology: the fifth generation of progress. Lippincott, Williams and Wilkins, Philadelphia, PA, pp 775–807
- Nicholson AN, Pascoe PA (1991) Presynaptic alpha 2-adrenoceptor function and sleep in man: studies with clonidine and idazoxan. Neuropharmacology 30:367–372 CrossRef
- Pace-Schott EF, Hobson JA (2002) Basic mechanisms of sleep: new evidence on the neuroanatomy and neuromodulation of the NREM–REM cycle. In: Davis KL, Charney D, Coyle JT, Nemeroff C (eds) American College of Neuropsychopharmacology: the fifth generation of progress. Lippincott, Williams and Wilkins, Philadelphia, PA, pp 1859–1877
- Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. U.S. Government Printing Office, Washington, DC
- Saletu B, Wessely P, Grünberger J, Schultes M (1987a). Erste klinische Erfahrungen mit einem neuen schlafanstossenden Benzodiacepin Cinolazepam mittels eines Selbstbeurteilungsbogens für Schalf—und Aufwachqualität (SSA). Neuropsychiatrie 1:169–176
- Saletu B, Anderer P, Kinsperger K, Grünberger J (1987b). Topographic brain mapping of EEG in neuropsychopharmacology—Part II. Clinical applications (pharmaco-EEG imaging). Methods Find Exp Clin Pharmacol 9:385–408
- Salin-Pascual RJ, Herrera-Estrella M, Galicia-Polo L, Rosas-Laurrabaquio M (1999) Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency. Biol Psychiatry 46:141–143 CrossRef
- Salin-Pascual RJ, Herrera-Estrella M, Galicia-Polo L, Rosas M, Brunner E (2004) Low delta sleep predicted a good clinical response to olanzapine administration in schizophrenic patients. Rev Invest Clin 56:345–350
- Schlösser R, Röschker J, Rossbach W, Benkert O (1998) Conventional and spectral power analysis of all-night sleep EEG after subchronic treatment with paroxetine in healthy male volunteers. Eur Neuropsychopharmacol 8:273–278 CrossRef
- Sharpley AL, Elliott JM, Attenburrow MJ, Cowen PJ (1994) Slow wave sleep in humans: Role of 5-HTA and 5HT2C receptors. Neuropharmacology 33:467–471 CrossRef
- Sharpley AL, Vassallo CM, Cowen PJ (2000) Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT2c receptors in vivo. Biol Psychiatry 47:468–470 CrossRef
- Sharpley AL, Bhagwagar Z, Hafizi S, Whale WR, Gijsman HJ, Cowen PJ (2003) Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients. J Clin Psychiatry 64:192–196 CrossRef
- Stephan FT, Tandon R, Shipley JE, Eiser AS (1991) Effect of neuroleptic treatment on polysomnographic measures in schizophrenia. Biol Psychiatry 30:904–912 CrossRef
- Tandon R (1998) Antipsychotic agents. In: Klein DF, Rowland LP (eds) Current psychotherapeutic drugs. Brunner/Mazel Publishers, New York, pp 120–154
- Viola AU, Brandenberger G, Toussaint M, Bouhours P, Macher JP, Luthringer R (2002) Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers. Clin Neurophysiol 113:429–434 CrossRef
- Warrington SJ (1997) Ethical aspects of research in healthy volunteers. In: O’Grady J, Joubert PH (eds) Handbook of phase I/II clinical drug trials. CRS Press, Boca Raton, pp 103–110
- Worrel JA, Marken PA, Beckman SE, Ruether VL (2000) Atypical antipsychotic agents: a critical review. Am J Health—Syst Pharm 57:238–255
- Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers
Volume 190, Issue 4 , pp 507-516
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Spectral analysis
- Subjective evaluations
- Healthy volunteers
- Single morning oral intake
- Industry Sectors
- Author Affiliations
- 1. Centre d’Investigació del Medicament, Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
- 3. Departament de Farmacologia i Terapèutica, UAB, Barcelona, Spain
- 4. Centre de Recerca en Enginyeria Biomèdica, Departament ESAII, UPC, Barcelona, Spain
- 2. Servei de Farmacologia Clínica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain